*In a 68- and 72-week clinical trial studying Semaglutide in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
After one month, patients can add the Precision Peptide Genetic Test for $99 to optimize their compound selection based on individual metabolic genetics
Please consult your personal legal, tax, or financial counsel for information about how this information applies to you or your entity.
What to Expect During Semaglutide Treatment Semaglutide is ideal for individuals with a body mass index (BMI) of 30 or greater or for adults with a BMI of 27 who also have at least one weight-related complication such as hypertension, insulin resistance, high cholesterol, or heart disease
1o, p and 2i)
It is likely that the peptide works through various biochemical pathways and may modify gene expression
